What is the catalog number for Lubiprostone-d7?

The catalog number for Lubiprostone-d7 is CS-O-06737.

What sizes are available for Lubiprostone-d7?

Lubiprostone-d7 is available in the following size(s): 1 Each.

Is Lubiprostone-d7 in stock?

Lubiprostone-d7 is currently made to order / not held in immediate stock. Contact us for lead time.

Where can I find the safety data sheet (SDS/MSDS) for Lubiprostone-d7?

The safety data sheet for Lubiprostone-d7 is available here: https://msds_v1.clearsynth.com/msds.asp?catnumber=CS-O-06737.

Lubiprostone-d7

Lubiprostone-d7 is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Lubiprostone. The product is supplied by Clearsynth under CAT No. CS-O-06737. Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.

Product Specifications

Overview

" Labelled Lubiprostone is a bicyclic fatty acid metabolite analog of Prostaglandin E1. It activates specific chloride channels in the gastrointestinal tract to stimulate intestinal fluid secretion, increase gastrointestinal transit, and improve symptoms; Labeled Lubiprostone, intended for use as an internal standard for the quantification of Lubiprostone by GC- or LC-mass spectrometry."

CAS Number

1217675-13-2

Synonyms

Lubiprostone-d7

Molecular Formula

C 20 H 25 D 7 F 2 O 5

Molecular Weight

397.51

Additionnal Information

Lubiprostone-d7 is supplied with detailed characterization data compliant with regulatory guideline. Lubiprostone-d7 can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Lubiprostone.

Storage Conditions

Refer MSDS for complete information.

Applications Notes

" Labelled Lubiprostone is a bicyclic fatty acid metabolite analog of Prostaglandin E1. It activates specific chloride channels in the gastrointestinal tract to stimulate intestinal fluid secretion, increase gastrointestinal transit, and improve symptoms; Labeled Lubiprostone, intended for use as an internal standard for the quantification of Lubiprostone by GC- or LC-mass spectrometry."